NovoCure (NVCR) Other Working Capital Changes (2014 - 2026)

NovoCure has disclosed Other Working Capital Changes across 13 years of filings, most recently posting -$2.8 million for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$2.8 million, down 153.08% year-over-year; the trailing twelve-month figure through Mar 2026 was -$7.0 million (down 22.29% YoY), and the FY2025 annual result was -$5.3 million, up 17.08% from the prior year.
• Other Working Capital Changes came in at -$2.8 million for Q1 2026 at NovoCure, down from -$2.6 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $920000.0 in Q2 2025 to a low of -$3.2 million in Q1 2023.
• The 5-year median for Other Working Capital Changes is -$1.8 million (2024), against an average of -$1.9 million.
• Across the five-year window, Other Working Capital Changes jumped 150.3% in 2025 and slumped 153.08% in 2026, its largest moves.
• NovoCure's Other Working Capital Changes stood at -$1.7 million in 2022, then slipped by 10.67% to -$1.8 million in 2023, then surged by 33.46% to -$1.2 million in 2024, then slumped by 115.05% to -$2.6 million in 2025, then decreased by 7.34% to -$2.8 million in 2026.
• The last three Other Working Capital Changes figures came in at -$2.8 million (Q1 2026), -$2.6 million (Q4 2025), and -$2.4 million (Q3 2025), per Business Quant data.